Kevin Weil on AI and Automated Labs

MTS17m 35s
Kevin Weil beside the headline AI Drug Discovery.
0 comments · 0 votesOpen discussionClose discussion
Sign in to join the discussion

    Warp Sciences co-founder Kevin Weil describes a proposed roboticsRobotics develops machines that sense their surroundings and perform physical actions through coordinated hardware and software. and AI laboratory service for preclinical small-molecule chemistry. He argues that experiments remain essentialExperimental validation tests a prediction or proposed mechanism with measured observations from a suitable real-world or laboratory experiment. and can produce data for scientific modelsAI-assisted scientific discovery uses AI to support hypothesis generation, experiment design, analysis, simulation, literature work, and interpretation while researchers retain responsibility..

    Weil discusses the economics and location of drug research and his expectations for automated labs. These are a founder’s claims and proposals; the company is still building its service.

    Original YouTube thumbnailWatch on YouTube

    Video topic coverage

    • Agents & workflows15
    • Coding & tools0
    • Models & learning45
    • Infrastructure & compute30
    • Research & evaluation100
    • Safety & security0
    • Business & productivity60
    • Creative & media0
    • Robotics & perception80
    • Society & policy25

    Share this video

    Kevin Weil beside the headline AI Drug Discovery. With WWW.ARTIFICIAL-INTELLIGENCE.VIDEO, 23 October 2026 and duration 17m 35s.

    Kevin Weil argues automated laboratories could generate data and support AI-assisted drug discovery.